Previous 10 | Next 10 |
Gainers: CRISPR Therapeutics AG (NASDAQ:CRSP) +26%. Micron Technology, Inc. (NASDAQ:MU) +15%. CVRx, Inc. (NASDAQ:CVRX) +11%. Academy Sports and Outdoors, Inc. (NASDAQ:ASO) +8%. KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) +6%. Losers: Gilat Satellite Networks Ltd. (NASDAQ:G...
CVRx, Inc. (CVRX) Q4 2021 Earnings Conference Call February 15, 2022, 05:30 PM ET Company Participants Nadim Yared – President & Chief Executive Officer Mike Vallie – Westwicke, ICR Company Jared Oasheim – Chief Financial Officer Conference Call Participants Robbie Ma...
CVRx press release (NASDAQ:CVRX): Q4 GAAP EPS of -$0.52 misses by $0.07. Revenue of $3.7M (+76.2% Y/Y) misses by $0.07M. For further details see: CVRx GAAP EPS of -$0.52 misses by $0.07, revenue of $3.7M misses by $0.07M
MINNEAPOLIS, Feb. 15, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and oper...
MINNEAPOLIS, Feb. 01, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans ...
MINNEAPOLIS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced certain prelim...
MINNEAPOLIS, Dec. 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the manag...
MINNEAPOLIS, Nov. 16, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, today a...
CVRx, Inc. (CVRX) Q3 2021 Earnings Conference Call November 04, 2021 05:30 PM ET Company Participants Mike Vallie - Westwicke, ICR Company Nadim Yared - President & Chief Executive Officer Jared Oasheim - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler...
CVRx (NASDAQ:CVRX): Q3 GAAP EPS of -$0.30 beats by $0.08. Revenue of $3.4M (+243.4% Y/Y) beats by $0.12M. Press Release As of September 30, 2021, cash and cash equivalents were $170.9M compared to $47.1M as of June 30, 2021. Net cash used in operating and investing activities was $9.4M for th...
News, Short Squeeze, Breakout and More Instantly...
MINNEAPOLIS, July 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device for patients with ca...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...
MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced the appointment of Robert John as Chief Revenue Officer effective June 27. In this role, John will lead the Company's US sales team with the objective of m...